4//SEC Filing
Fischer Laurent 4
Accession 0001379344-25-000004
CIK 0001501756other
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 9:45 PM ET
Size
7.3 KB
Accession
0001379344-25-000004
Insider Transaction Report
Form 4
Fischer Laurent
DirectorCEO, PRESIDENT AND DIRECTOR
Transactions
- Purchase
Common Stock
2025-12-05$4.24/sh+11,085$47,000→ 83,899 total - Purchase
Common Stock
2025-12-08$4.31/sh+117,614$506,916→ 201,513 total
Footnotes (3)
- [F1]Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $4.21 to $4.25. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
- [F2]Includes 600 shares purchased on May 21, 20125 and 600 shares purchased on November 20, 2025, pursuant to the Issuer's 2014 Employee Stock Purchase Plan, as amended and restated.
- [F3]Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $4.25 to $4.32. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
Documents
Issuer
Adverum Biotechnologies, Inc.
CIK 0001501756
Entity typeother
Related Parties
1- filerCIK 0001379344
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 9:45 PM ET
- Size
- 7.3 KB